Acerinox
OTCMKTS:ANIOYAcerinox, S.A., together with its subsidiaries, manufactures, process, and markets stainless steel products in Spain, the United States, Africa, Asia, Rest of Europe, and internationally. It operates through Stainless steel, and High-performance Alloys segments. The company offers flat products, including hot and cold rolled coils and sheets, strips, flat bars, and discs, as well as engraved coil and sheet, black coil, slabs, circles, billets, and plates. It provides long products, which include wire and hexagonal wire rods, peeled bars, hot and cold reinforcement bars, black bars, profiles, angles, and steel profiles, as well as stainless steel, color coated, and reinforcement wires. In additions, it offers stainless steel products, such as austenitic, ferritic, duplex, and martensitic. Acerinox, S.A. was incorporated in 1970 and is headquartered in Madrid, Spain.
C.P. Pokphand
OTCMKTS:CPKPYCP Pokphand Co. Ltd. is an investment holding company, which engages in the manufacture and trade of animal feed products. It operates through the following business segments: China Agri-Food; Vietnam Agri-Food; and Investment and Property Holding. The China Agri-Food segment produces and distributes animal feed and processed food. The Vietnam Agri-Food segment breeds, farms, and sells livestock and aquatic animals. The Investment and Property Holding segment manages and leases out residential and commercial projects. The company was founded in 1987 and is headquartered in Hong Kong.
freenet
OTCMKTS:FRTAFfreenet AG provides telecommunications, radio and multimedia, mobile communications, mobile Internet, and digital lifestyle services in Germany. It operates through Mobile Communications, TV and Media, and Other/Holding segments. The Mobile Communications segment engages in the marketing of mobile communications services, which include voice and data services from the mobile communications network operators; planning, construction, installation, and maintenance services for WiFi networks; and selling and distribution of mobile communications devices, as well as offers additional services for mobile data communications and digital lifestyle. This segment also provides app-based Internet products. The TV and Media segment is involved in the planning, project management, installation, operation, service, and marketing services for broadcast-related solutions for business clients in the radio and media sectors; and the provision of services to end users in the field of DVB-T2 and IPTV. The Other/Holding segment offers portal services, such as e-commerce/advertising services; payment services; various digital products and entertainment formats for downloading and displaying, as well as use on mobile devices; communication development solutions, IT solutions, and other services; and voice and data services. The company provides its services under the klarmobil.de, freenetmobile.de, callmobile.de, freenet FLEX, freenet MOBILE, FUNK, freenet TV, waipu.tv, freenet VIDEO, freenet.de, GRAVIS, freenet BASICS, freenet ENERGY, freenet BUSINESS, CARMADA, MEDIA BROADCAST, vitrado.de, and The Cloud brands. It sells its products through electronics stores, as well as online platforms. freenet AG was founded in 2005 and is headquartered in Büdelsdorf, Germany.
Pharma Mar
OTCMKTS:PHMMFPharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14, which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trial for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trial for treating solid tumors; Tivanisiran, which is in Phase III clinical trial for the treatment of dry eye disease; and SYL1801 that is in phase II clinical trial for treating macular degeneration. In addition, it engages in the development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. The company was incorporated in 1986 and is based in Madrid, Spain.
Woolworths
OTCMKTS:WLWHYWoolworths Holdings Limited, through its subsidiaries, operates a chain of retail stores in sub-Saharan Africa, Australia, and New Zealand. It operates through seven segments: Woolworths Fashion, Beauty and Home; Woolworths Food; Woolworths Financial Services; David Jones; Country Road Group; and Treasury. The company provides food, clothing, homeware, beauty, and various lifestyle products, as well as operates department stores. It offers financial products and services, such as store cards, credit cards, personal loans, and other financial products. The company is also involved in the cash and debt management activities. Woolworths Holdings Limited was founded in 1931 and is based in Cape Town, South Africa.